244 related articles for article (PubMed ID: 12069000)
1. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
Boutsen F; Cannito MP; Taylor M; Bender B
J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
[TBL] [Abstract][Full Text] [Related]
2. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
Blitzer A
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
[TBL] [Abstract][Full Text] [Related]
4. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
5. Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia.
Bielamowicz S; Stager SV; Badillo A; Godlewski A
J Voice; 2002 Mar; 16(1):117-23. PubMed ID: 12002878
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
Sulica L; Blitzer A; Brin MF; Stewart CF
Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
Blitzer A; Brin MF; Stewart CF
Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
[TBL] [Abstract][Full Text] [Related]
8. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
van Esch BF; Wegner I; Stegeman I; Grolman W
Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
[TBL] [Abstract][Full Text] [Related]
9. Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.
Cannito MP; Kahane JC; Chorna L
Clin Interv Aging; 2008; 3(1):131-51. PubMed ID: 18488884
[TBL] [Abstract][Full Text] [Related]
10. Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection.
Sapienza CM; Cannito MP; Murry T; Branski R; Woodson G
J Speech Lang Hear Res; 2002 Oct; 45(5):830-43. PubMed ID: 12381042
[TBL] [Abstract][Full Text] [Related]
11. The short-term impact of Botox injections on speech disability in adductor spasmodic dysphonia.
Epstein R; Stygall J; Newman S
Disabil Rehabil; 1997 Jan; 19(1):20-5. PubMed ID: 9021281
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
[TBL] [Abstract][Full Text] [Related]
13. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
Bielamowicz S; Ludlow CL
Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
15. Voice handicap index results for older patients with adductor spasmodic dysphonia.
Wingate JM; Ruddy BH; Lundy DS; Lehman J; Casiano R; Collins SP; Woodson GE; Sapienza C
J Voice; 2005 Mar; 19(1):124-31. PubMed ID: 15766857
[TBL] [Abstract][Full Text] [Related]
16. Speech intelligibility in severe adductor spasmodic dysphonia.
Bender BK; Cannito MP; Murry T; Woodson GE
J Speech Lang Hear Res; 2004 Feb; 47(1):21-32. PubMed ID: 15072525
[TBL] [Abstract][Full Text] [Related]
17. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study.
Mendelsohn AH; Berke GS
Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926
[TBL] [Abstract][Full Text] [Related]
18. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle.
Maronian NC; Waugh PF; Robinson L; Hillel AD
Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760
[TBL] [Abstract][Full Text] [Related]
19. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy.
Murry T; Woodson GE
J Voice; 1995 Dec; 9(4):460-5. PubMed ID: 8574315
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
Casserly P; Timon C
J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]